
Hawkins, Inc. (NASDAQ:HWKN – Free Report) – BWS Financial decreased their Q4 2026 earnings per share (EPS) estimates for Hawkins in a report released on Monday, November 3rd. BWS Financial analyst H. Khorsand now forecasts that the specialty chemicals company will earn $0.80 per share for the quarter, down from their previous forecast of $1.00. BWS Financial currently has a “Buy” rating and a $200.00 target price on the stock. The consensus estimate for Hawkins’ current full-year earnings is $4.00 per share. BWS Financial also issued estimates for Hawkins’ Q1 2027 earnings at $1.51 EPS, Q2 2027 earnings at $1.35 EPS, Q3 2027 earnings at $0.97 EPS and Q4 2027 earnings at $1.00 EPS.
Hawkins (NASDAQ:HWKN – Get Free Report) last posted its quarterly earnings data on Wednesday, October 29th. The specialty chemicals company reported $1.08 earnings per share for the quarter, missing analysts’ consensus estimates of $1.24 by ($0.16). The firm had revenue of $280.43 million during the quarter, compared to analysts’ expectations of $284.42 million. Hawkins had a net margin of 7.95% and a return on equity of 17.79%.
Read Our Latest Research Report on HWKN
Hawkins Stock Down 8.1%
HWKN stock opened at $130.38 on Tuesday. The stock has a market capitalization of $2.72 billion, a PE ratio of 32.76, a price-to-earnings-growth ratio of 2.25 and a beta of 0.84. The company has a fifty day moving average of $169.78 and a 200-day moving average of $153.13. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.45 and a current ratio of 2.31. Hawkins has a one year low of $98.30 and a one year high of $186.15.
Institutional Investors Weigh In On Hawkins
A number of hedge funds and other institutional investors have recently modified their holdings of HWKN. Salomon & Ludwin LLC acquired a new stake in shares of Hawkins in the 3rd quarter worth approximately $27,000. Brooklyn Investment Group raised its holdings in Hawkins by 533.3% during the first quarter. Brooklyn Investment Group now owns 266 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 224 shares during the last quarter. Whittier Trust Co. of Nevada Inc. boosted its position in Hawkins by 118.8% during the first quarter. Whittier Trust Co. of Nevada Inc. now owns 280 shares of the specialty chemicals company’s stock worth $30,000 after purchasing an additional 152 shares in the last quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in Hawkins in the second quarter valued at $31,000. Finally, First Horizon Corp acquired a new stake in Hawkins in the third quarter valued at $34,000. 69.71% of the stock is currently owned by institutional investors and hedge funds.
Hawkins Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, November 28th. Shareholders of record on Friday, November 14th will be given a dividend of $0.19 per share. This represents a $0.76 annualized dividend and a yield of 0.6%. The ex-dividend date is Friday, November 14th. Hawkins’s dividend payout ratio is presently 19.10%.
Hawkins Company Profile
Hawkins, Inc operates as a specialty chemical and ingredients company in the United States. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries.
Further Reading
- Five stocks we like better than Hawkins
- Dividend Payout Ratio Calculator
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Insider Trades May Not Tell You What You Think
- The Best Local Butchers for Thanksgiving [2025 Survey]
- The Basics of Support and Resistance
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Hawkins Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hawkins and related companies with MarketBeat.com's FREE daily email newsletter.
